CUHK study reveals effective prevention for preterm preeclampsia

Early screening has been shown to reduce risks of preterm preeclampsia by 41%.

The Department of Obstetrics and Gynaecology at The Chinese University of Hong Kong’s Faculty of Medicine conducted a study on the efficacy, acceptance, and safety of an early screen-and-prevent strategy for preterm preeclampsia.

The research screened 42,897 women at 11-13 weeks of pregnancy between August 2019 and February 2022 using the FMF triple test to predict preterm preeclampsia. High-risk women received low-dose aspirin from before 16 weeks until 36 weeks.

Results showed that the procedure reduced the risks of preterm preeclampsia and early onset preeclampsia by 41% and 54% respectively. The risks of spontaneous preterm birth and perinatal death also decreased by 55% and 66%.

In addition, 88% of participating Asian women accepted this screening strategy.

Preeclampsia is a condition that causes many maternal and perinatal complications. It affects 2% to 8% of pregnant women globally, resulting in 76,000 women and 500,000 babies dying each year from the disorder during pregnancy.

Follow the link for more news on

healthcare

Also Read

Government updates preservatives and antioxidants standards

HK and Macau conduct drill for cross-boundary ambulances scheme

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit